在9月份,Exscientia的空头股票下跌了9.7%,至289万股. In September, Exscientia's short interest dropped by 9.7% to 2,890,000 shares.

Exscientia 是一家专注于人工智能的制药公司，9 月份空头股数下跌了 9.7%，总计 2,890,000 股。 Exscientia, an AI-focused pharmaceutical company, experienced a 9.7% drop in short interest in September, totaling 2,890,000 shares. 其空头股数比率为 4.3 天，有 2.7% 的股票卖空。 Its short-interest ratio stands at 4.3 days, with 2.7% of shares sold short. 该公司正在推举其主要候选人GTAEXS617,这是一家CDK7在审判中的抑制剂。 The firm is advancing its lead candidate, GTAEXS617, a CDK7 inhibitor in trials. Exscientia 的市值为 6.1169 亿美元，债务权益比率为 0.06，最近来自 Novo Holdings 等公司的显着投资。 Exscientia has a market cap of $611.69 million and a low debt-to-equity ratio of 0.06, with notable recent investments from firms like Novo Holdings.